Trapani, D.
Giugliano, F.
Uliano, J.
Zia, V. A. A.
Marra, A.
Viale, G.
Ferraro, E.
Esposito, A.
Criscitiello, C.
D’amico, P.
Curigliano, G. http://orcid.org/0000-0003-1781-2518
Funding for this research was provided by:
Ministero della Salute (000001)
Article History
Received: 15 March 2021
Accepted: 11 May 2021
First Online: 27 May 2021
Declarations
:
: GF, UJ, AM, EF, GV, DT, PD, EA declare no potential COI. GC has received honoraria from Pfizer, Novartis, Lilly, Roche; fees for expert testimony and medical education from Pfizer; and has participated in advisory board s for Pfizer, Roche, Lilly, Novartis, Seattle Genetics, Celltrion. All the declarations are outside the submitted work. CC, received honoraria for speaker bureau, consultancy or advisory role from Roche, Novartis, Pfizer, Eli-Lilly, and MSD. VAAZ is also employee from Takeda Oncology. No COI in this submitted work.